Firefly BioWorks
Cambridge, Massachusetts, United States
About Firefly BioWorks
Firefly BioWorks, Inc. (Cambridge, MA) is introducing an open platform allowing industrial, academic and clinical scientists to develop and use multiplexed biological assays on standard laboratory instrumentation. The company's core technology, Optical Liquid Stamping, was developed in the Chemical Engineering Department at MIT (News - Alert) by Firefly co-founders. The method allows rapid and scalable synthesis of encoded, multi-functional particles for the quantification of biological function. The company's long-term vision is to provide research and clinical scientists with reliable and affordable solutions for the comprehensive monitoring of biological systems.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.4M
- Funding stage: M&A
- Last round: Debt Financing (Jul 2014)
- Website: fireflybio.com
- Phone: 6175006246
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/firefly-bioworks-2458386 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.